Compare SPGI & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPGI | MCK |
|---|---|---|
| Founded | 1860 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.6B | 99.7B |
| IPO Year | 1994 | 1995 |
| Metric | SPGI | MCK |
|---|---|---|
| Price | $415.00 | $754.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 14 |
| Target Price | $558.33 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.90% | 0.40% |
| EPS Growth | 18.70 | ★ 49.22 |
| EPS | 4.69 | ★ 38.38 |
| Revenue | $6,063,000,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $9.66 | $14.94 |
| Revenue Next Year | $7.35 | $8.21 |
| P/E Ratio | $88.52 | ★ $19.68 |
| Revenue Growth | ★ 7.10 | 3.11 |
| 52 Week Low | $381.61 | $637.00 |
| 52 Week High | $579.05 | $999.00 |
| Indicator | SPGI | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 37.72 |
| Support Level | $403.41 | $726.86 |
| Resistance Level | $450.12 | $779.31 |
| Average True Range (ATR) | 10.93 | 20.61 |
| MACD | 0.20 | 4.24 |
| Stochastic Oscillator | 44.33 | 51.76 |
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include energy (formerly commodity insights, this segment includes Platts and other data), mobility (Carfax), and indexes. S&P plans to spin off mobility in 2026.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.